SCHEMBL1907253

SCHEMBL1907253

NS(=O)(=O)c1cccc2c3c(ccc12)=NC(=O)C(=O)N=3

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 1/20 0.49
CA2 P00918 7/20 0.46
CA1 P00915 6/20 0.46
CA9 Q16790 5/20 0.46
PNMT P11086 1/20 0.43
LDHA P00338 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.37
ATIC P31939 1/20 0.36
FTO Q9C0B1 1/20 0.36
MAPK1 P28482 1/20 0.35
CA6 P23280 3/20 0.34
CA5A P35218 3/20 0.34
CA4 P22748 2/20 0.34
CYP2C9 P11712 2/20 0.34
CA12 O43570 2/20 0.34
CA7 P43166 2/20 0.34
CA5B Q9Y2D0 2/20 0.34
CA14 Q9ULX7 1/20 0.34
STAT3 P40763 1/20 0.34
TTR P02766 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9138970 0.75 CDK2 (0.78) CDK2CA2CA1CA9PNMT
SCHEMBL222006 0.73 KMT2A (0.54) CDK2CA2CA1CA9CA5A
SCHEMBL10577721 0.69 CA2 (0.64) CDK2CA2CA1CA9PNMT
SCHEMBL7942707 0.67 ALDH1A1 (0.42) CA2CA1SMN1; SMN2HSD17B10KDM4E
SCHEMBL15851423 0.66 CDK2 (0.70) CDK2CA2CA1CA9PNMT
SCHEMBL1804410 0.66 CDK2 (0.64) CDK2CA2CA1CA9PNMT
SCHEMBL29401806 0.66 CDK2 (1.00) CDK2CA2CA1CA9PNMT
SCHEMBL588923 0.66 CDK2 (1.00) CDK2CA2CA1CA9PNMT
SCHEMBL1803500 0.66 TTR (0.68) CDK2CA2CA1CA9LDHA
SCHEMBL9669785 0.66 CDK2 (0.58) CDK2CA2CA1CA9PNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2317316-A2 Methods for identifying agent and conditions that modulate neurogenesis Braincells, Inc. (US) 2011-05-04 EP disclosed
EP-1904843-A2 METHODS FOR IDENTIFYING AGENTS AND CONDITIONS THAT MODULATE NEUROGENESIS Braincells, Inc. (US) 2008-04-02 EP disclosed
US-20070015138-A1 Methods for identifying agents and conditions that modulate neurogenesis BRAINCELLS, INC. (US) 2007-01-18 US disclosed
WO-2007008758-A2 METHODS FOR IDENTIFYING AGENTS AND CONDITIONS THAT MODULATE NEUROGENESIS BRAINCELLS, INC. (US) 2007-01-18 WO disclosed